Oslo, Norway, October 25, 2023- Datum AS has today acquired 500,000 shares in Nykode Therapeutics ASA at an average price of NOK 17.82 per share. Harald Arnet is the CEO of Datum AS and is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction Datum AS holds 12,560,250 shares in the company.

For further details, please see the attached form.